The air hums with the quiet intensity of discovery. This is the New Drug Development Research Center in Guangzhou. Here amidst the bustling city lies a place dedicated to scientific advancement.
This center isn’t just a building. It’s a hub of collaboration. It’s a partnership between industry and academia. Specifically it’s a joint venture between Ankang Pharmaceutical and Guangdong Pharmaceutical University. Established in a modern facility in the Haizhu district the center serves as Ankang’s new drug development heart. It also serves as a vital training ground for undergraduate and postgraduate students.
In 2017 the center received significant recognition. It won the Guangzhou Municipal Science and Technology Innovation Commission’s “Little Giant” designation. This prestigious award brought substantial government funding. This funding enabled the expansion of the Center’s research capabilities.
The center boasts a team of over 20 employees. Most hold bachelor’s degrees or higher. Their expertise spans various scientific disciplines. They have a PhD and eight Masters graduates among their staff. This team creates a powerful synergy of knowledge and skills.
The impressive laboratory facilities are state-of-the-art. There are seven standardized testing labs. These labs house advanced equipment like Waters 515 and Shimadzu LC-15C HPLC systems. There is also a sophisticated mass spectrometry system. These resources enable comprehensive drug analysis and testing. The Center meets all the requirements of the State Market Supervision and Administration. A dedicated team ensures the quality control of all experiments. They implemented a digital data management system for complete traceability.
Beyond independent research the New Drug Development Research Center actively seeks collaborations. It works with numerous national and international research institutions. These collaborations involve Guangdong Pharmaceutical University Sun Yat-sen University and many more. These partnerships enhance the center’s research scope.
The center focuses on several key areas including lipid nanoparticles. They work on pediatric medications and cerebrovascular treatments. They have made significant strides in developing effective antidotes for organophosphate poisoning. Progress is also evident in new formulations for hemodynamic drugs and brain-targeted emergency drugs. The research on these crucial areas has yielded breakthroughs. Some products are already in the registration phase.
To protect its intellectual property the Center has obtained nearly 30 patents. This safeguards the results of their innovative work. The New Drug Development Research Center embodies Ankang Pharmaceutical’s core values. These values prioritize trust integrity and responsibility. The center strives for excellence. It seeks to develop innovative drugs and establish itself as a leader in the field. It continues to enhance its own facilities and build upon its already impressive foundation. It does this through independent research and international collaborations. The New Drug Development Research Center is poised to continue its groundbreaking work. It aims to create a lasting impact on the pharmaceutical industry and beyond.